Relationship between pre-implant interleukin-6 levels, inflammatory response, and early outcome in patients supported by left ventricular assist device: A prospective study

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Caruso, Raffaele ^a   Botta, Luca ^a   Verde, Alessandro ^a   Milazzo, Filippo ^a   Vecchi, Irene ^a   Trivella, Maria Giovanna ^b   Martinelli, Luigi ^a   Paino, Roberto ^a   Frigerio, Maria ^a   Parodi, Oberdan ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INTERLEUKIN 6; INTERLEUKIN 8; NEOPTERIN;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; DEATH; DISEASE ASSOCIATION; EMBOLISM; ESOPHAGUS HEMORRHAGE; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LEFT VENTRICULAR ASSIST DEVICE; LEUKOCYTE COUNT; LIVER DYSFUNCTION; MALE; MENTAL DISEASE; MONOCYTE; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESPIRATORY FAILURE; SEPSIS; SEPTIC SHOCK; SURVIVAL TIME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOPTERIN; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84897091025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090802     Document Type: Article

References (24)

1. Lund LH, Matthews J, Aaronson K (2010) Patient selection for left ventricular assist devices. Eur J Heart Fail 12: 434-443.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. ESC Committee for Practice Guidelines (CPG). (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al American College of Cardiology Foundation; American Heart Association. (2009) 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479.
4. Wilson SR, Mudge GH, Stewart Jr GC, Givertz MM (2009) Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation 119: 2225-2232.
5. Shiga T, Kinugawa K, Hatano M, Yao A, Nishimura T, et al. (2011) Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J 75: 121-128.
6. Caruso R, Trunfio S, Milazzo F, Campolo J, De Maria R, et al. (2010) Early expression of pro- and anti-Inflammatory cytokines in left ventricular assist device recipients with multiple organ failure syndrome. ASAIO J 56: 313-318.
7. Masai T, Sawa Y, Ohtake S, Nishida T, Nishimura M, et al. (2002) Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation. Ann Thorac Surg 73: 549-555. (Pubitemid 34117408)
8. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, et al International Society for Heart and Lung Transplantation. (2005) Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: Third Annual Report-2005. J Heart Lung Transplant 24: 1182-1187. (Pubitemid 41247796)
9. Caruso R, Verde A, Cabiati M, Milazzo F, Boroni C, et al. (2012) Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients. J Heart Lung Transplant 31: 625-633.
10. Wiel E, Vallet B, ten Cate H (2005) The endothelium in intensive care. Crit Care Clin 21: 403-416. (Pubitemid 40898151)
11. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, et al. (2005) ESC Committee for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26: 384-416. (Pubitemid 40283098)
12. Minne L, Abu-Hanna A, de Jonge E (2008) Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care 12: R161.
13. Palardy M, Nohria A, Rivero J, Lakdawala N, Campbell P, et al. (2010) Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail 16: 218-224.
14. Levey AS, Greene T, Kusek JW, Beck GJ (2000) Simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11: 828A.
15. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL (2001) Serial evaluation of the t-SOFA score to predict outcome in critically ill patients. JAMA 286: 1754-1758. (Pubitemid 33010262)
16. De Rosa S, Cirillo P, Pacileo M, Petrillo G, D'Ascoli GL, et al. (2011) Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. Curr Vasc Pharm 9: 188-199.
17. Castellani ML, De Lutiis MA, Toniato E, Conti F, Felaco P, et al. (2012) Impact of RANTES, MCP-1 and IL-8 in mast cells. J Biol Regul Homeost Agents 24: 1-6.
18. Brasier AR (2010) The nuclear factor-kB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86: 211-218.
19. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R (2000) Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87: 241-247. (Pubitemid 30626433)
20. Herpfer I, Greilberger J, Ledinski G, Widner B, Fuchs D, et al. (2002) Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper. Free Radic Res 36: 509-520. (Pubitemid 36285023)
21. Kirsch M, Boval B, Damy T, Ghendouz S, Vermes E, et al. (2012) Importance of monocyte deactivation in determining early outcome after ventricular assist device implantation. Int J Artif Organs 35: 169-176.
22. Walsh DS, Thavichaigarn P, Pattanapanyasat K, Siritongtaworn P, Kongcharoen P, et al. (2005) Characterization of circulating monocytes expressing HLADR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury. J Surg Res 29: 221-230. (Pubitemid 41799594)
23. Ploder M, Pelinka L, Schmuckenschlager C, Wessner B, Ankersmit HJ, et al. (2006) Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 25: 129-134.
24. Muller Kobold AC, Tulleken JE, Zijlstra JG, Sluiter W, Hermans J, et al. (2000) Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 26: 883-892. (Pubitemid 30616041)